5:40 PM
 | 
Jun 13, 2014
 |  BC Extra  |  Company News

Takeda ends Affymax deal, to pull Omontys NDA

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) is ending a 2006 deal with Affymax Inc. (OTCQB:AFFY) to co-develop and co-commercialize Omontys peginesatide, effective Sept. 10. The pharma...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >